2Georgiadis AN, Papavasiliou EC, Lourida ES, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study[J]. Arthritis Res Ther, 2006,8 (3) : R82.
3Kim SH, Lee CK, Lee EY, et al. Serum oxidized iowdensity lipoproteins in rheumatoid arthritis[J]. Rheumatol Int, 2004,24(4) : 230-233.
4Cesur M, Ozbalkan Z, Temel MA, et al. Ethnieity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis[J]. Clin Rheumatol, 2007, 26 (3) : 355-361.
5Goodson N. Coronary artery disease and rheumatoid arthritis[J]. Curr Opin Rheumatol, 2002, 14 (2) : 115- 120.
6Tam LS, GladmanDD, Hallett DC, et al. Effect of antimalarial agents in the fasting lipid profile in systemic lupus erythematosus [J]. Rheumatol, 2000, 27 : 2142- 2145.
7Choi HK, Heman MA, Seeger JD,et al. Methotrexate and mortality inpatients with rheumatoid arthritis: a prospective study[J]. Lancet, 2002,359:1173-1177.
8Boers M, Nurmohamohamed MT, Doelman CJ, et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2003, 62: 842-845.
9Watson DJ, Rhodes T, Guess HA. All-causemortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database[J]. Rheumatol, 2003, 30:1196-1202.
